<?xml version="1.0" encoding="UTF-8"?><lom:lom xmlns:lom="http://ltsc.ieee.org/xsd/LOM" xmlns:lomfr="http://www.lom-fr.fr/xsd/LOMFR" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://ltsc.ieee.org/xsd/lomv1.0/lom.xsd">
<lom:general>
<lom:identifier>
<lom:catalog>Doc'UMVF</lom:catalog>
<lom:entry>OAI_UMVF_DOC_31266</lom:entry>
</lom:identifier>
<lom:title>
<lom:string language="fre">BPCO</lom:string>
</lom:title>
<lom:language>fre</lom:language>
<lom:description>
<lom:string language="fre">LABA + corticostéroïde inhalé ou tiotropium ? - "Chez des patients présentant une BPCO sévère ou très sévère, quelle est l'efficacité relative de l'association d'un LABA (salmétérol 50 µg 2x/j) à un corticostéroïde inhalé (fluticasone 500 µg 2x/j) versus tiotropium 18 µg/j inhalé en termes de prévention des exacerbations et critères associés?"</lom:string>
</lom:description>
<lom:keyword>
<lom:string language="fre">Bromure de tiotropium</lom:string>
</lom:keyword>
<lom:keyword>
<lom:string language="fre">Xinafoate de salmétérol</lom:string>
</lom:keyword>
<lom:keyword>
<lom:string language="fre">administration par inhalation</lom:string>
</lom:keyword>
<lom:keyword>
<lom:string language="fre">association de médicaments</lom:string>
</lom:keyword>
<lom:keyword>
<lom:string language="fre">broncho-pneumopathie chronique obstructive</lom:string>
</lom:keyword>
<lom:keyword>
<lom:string language="fre">bronchodilatateurs</lom:string>
</lom:keyword>
<lom:keyword>
<lom:string language="fre">dérivés de la scopolamine</lom:string>
</lom:keyword>
<lom:keyword>
<lom:string language="fre">hormones corticosurrénaliennes</lom:string>
</lom:keyword>
<lom:keyword>
<lom:string language="fre">résultat thérapeutique</lom:string>
</lom:keyword>
<lomfr:documentType>
<lomfr:source>LOMFRv1.0</lomfr:source>
<lomfr:value>texte</lomfr:value>
</lomfr:documentType>
</lom:general>
<lom:technical>
<lom:format>text/html</lom:format>
<lom:location>http://www.minerva-ebm.be/fr/article/541</lom:location>
</lom:technical>
<lom:educational>
<lom:intendedEndUserRole>
<lom:source>LOMv1.0</lom:source>
<lom:value>learner</lom:value>
</lom:intendedEndUserRole>
<lom:context>
<lom:source>LOMv1.0</lom:source>
<lom:value>higher education</lom:value>
</lom:context>
</lom:educational>
<lom:lifeCycle>
<lom:contribute>
<lom:role>
<lom:source>LOMv1.0</lom:source>
<lom:value>author</lom:value>
</lom:role>
<lom:entity/>
<lom:date>
<lom:dateTime>2008-01-01</lom:dateTime>
</lom:date>
</lom:contribute>
<lom:contribute>
<lom:role>
<lom:source>LOMv1.0</lom:source>
<lom:value>publisher</lom:value>
</lom:role>
<lom:entity>BEGIN:VCARD
VERSION:3.0
N:Minerva ; Revue d'Evidence;Based Medicine
FN:Minerva ; Revue d'Evidence;Based Medicine
ORG:Minerva ; Revue d'Evidence;Based Medicine
EMAIL;TYPE=INTERNET:
END:VCARD
</lom:entity>
<lom:date>
<lom:dateTime>2008-01-01</lom:dateTime>
</lom:date>
</lom:contribute>
</lom:lifeCycle>
<lom:metaMetadata>
<lom:contribute>
<lom:role>
<lom:source>LOMv1.0</lom:source>
<lom:value>validator</lom:value>
</lom:role>
<lom:entity>BEGIN:VCARD
VERSION:3.0
N:CISMeF;CISMeF
FN:CISMeF CISMeF
ORG:CHU de Rouen
URL:http://www.chu-rouen.fr/cismef
UID:cismef
END:VCARD</lom:entity>
<lom:date>
<lom:dateTime/>
</lom:date>
</lom:contribute>
<lom:metadataSchema>LOMv1.0</lom:metadataSchema>
<lom:metadataSchema>LOMFRv1.0</lom:metadataSchema>
<lom:metadataSchema>SupLOMFRv1.0</lom:metadataSchema>
<lom:language>fre</lom:language>
</lom:metaMetadata>
<lom:rights>
<lom:cost>
<lom:source>LOMv1.0</lom:source>
<lom:value>no</lom:value>
</lom:cost>
<lom:copyrightAndOtherRestrictions>
<lom:source>LOMv1.0</lom:source>
<lom:value>yes</lom:value>
</lom:copyrightAndOtherRestrictions>
<lom:description>
<lom:string language="fre">Se renseigner auprès des auteurs</lom:string>
</lom:description>
</lom:rights>
<lom:classification>
<lom:purpose>
<lom:source>LOMv1.0</lom:source>
<lom:value>security level</lom:value>
</lom:purpose>
<lom:taxonPath>
<lom:source>
<lom:string language="fre">Projet OCW France</lom:string>
<lom:string language="eng"/>
</lom:source>
<lom:taxon>
<lom:id>tag-ocw</lom:id>
<lom:entry>
<lom:string language="fre">Catalogue OCWC</lom:string>
<lom:string language="eng"/>
</lom:entry>
</lom:taxon>
</lom:taxonPath>
</lom:classification>
<lom:classification>
<lom:purpose>
<lom:source>LOMv1.0</lom:source>
<lom:value>discipline</lom:value>
</lom:purpose>
<lom:taxonPath>
<lom:source>
<lom:string language="fre">CDD 22e ed</lom:string>
<lom:string language="eng"/>
</lom:source>
<lom:taxon>
<lom:id>615.718</lom:id>
<lom:entry>
<lom:string language="fre">615.718 - Médicaments agissant sur l'appareil respiratoire</lom:string>
<lom:string language="eng"/>
</lom:entry>
</lom:taxon>
</lom:taxonPath>
<lom:taxonPath>
<lom:source>
<lom:string language="fre">CDD 22e ed</lom:string>
<lom:string language="eng"/>
</lom:source>
<lom:taxon>
<lom:id>616.234</lom:id>
<lom:entry>
<lom:string language="fre">616.234 - Bronchite</lom:string>
<lom:string language="eng"/>
</lom:entry>
</lom:taxon>
</lom:taxonPath>
</lom:classification>
<lom:classification>
<lom:purpose>
<lom:source>LOMv1.0</lom:source>
<lom:value>idea</lom:value>
</lom:purpose>
<lom:taxonPath>
<lom:source>
<lom:string language="fre">MeSH http://mesh.inserm.fr/mesh/</lom:string>
<lom:string language="eng">MeSH Indexing http://www.nlm.nih.gov/mesh</lom:string>
</lom:source>
<lom:taxon>
<lom:id>D012602/Q000000/N</lom:id>
<lom:entry>
<lom:string language="fre">dérivés de la scopolamine//N</lom:string>
<lom:string language="eng">scopolamine derivatives//N</lom:string>
</lom:entry>
</lom:taxon>
</lom:taxonPath>
<lom:taxonPath>
<lom:source>
<lom:string language="fre">MeSH http://mesh.inserm.fr/mesh/</lom:string>
<lom:string language="eng">MeSH Indexing http://www.nlm.nih.gov/mesh</lom:string>
</lom:source>
<lom:taxon>
<lom:id>D029424/Q000188/O</lom:id>
<lom:entry>
<lom:string language="fre">broncho-pneumopathie chronique obstructive/traitement médicamenteux/O</lom:string>
<lom:string language="eng">pulmonary disease, chronic obstructive/drug therapy/Y</lom:string>
</lom:entry>
</lom:taxon>
</lom:taxonPath>
<lom:taxonPath>
<lom:source>
<lom:string language="fre">MeSH http://mesh.inserm.fr/mesh/</lom:string>
<lom:string language="eng">MeSH Indexing http://www.nlm.nih.gov/mesh</lom:string>
</lom:source>
<lom:taxon>
<lom:id>D001993/Q000627/O</lom:id>
<lom:entry>
<lom:string language="fre">bronchodilatateurs/usage thérapeutique/O</lom:string>
<lom:string language="eng">bronchodilator agents/therapeutic use/Y</lom:string>
</lom:entry>
</lom:taxon>
</lom:taxonPath>
<lom:taxonPath>
<lom:source>
<lom:string language="fre">MeSH http://mesh.inserm.fr/mesh/</lom:string>
<lom:string language="eng">MeSH Indexing http://www.nlm.nih.gov/mesh</lom:string>
</lom:source>
<lom:taxon>
<lom:id>D000280/Q000000/O</lom:id>
<lom:entry>
<lom:string language="fre">administration par inhalation//O</lom:string>
<lom:string language="eng">administration, inhalation//Y</lom:string>
</lom:entry>
</lom:taxon>
</lom:taxonPath>
<lom:taxonPath>
<lom:source>
<lom:string language="fre">MeSH http://mesh.inserm.fr/mesh/</lom:string>
<lom:string language="eng">MeSH Indexing http://www.nlm.nih.gov/mesh</lom:string>
</lom:source>
<lom:taxon>
<lom:id>D000305/Q000627/O</lom:id>
<lom:entry>
<lom:string language="fre">hormones corticosurrénaliennes/usage thérapeutique/O</lom:string>
<lom:string language="eng">adrenal cortex hormones/therapeutic use/Y</lom:string>
</lom:entry>
</lom:taxon>
</lom:taxonPath>
<lom:taxonPath>
<lom:source>
<lom:string language="fre">MeSH http://mesh.inserm.fr/mesh/</lom:string>
<lom:string language="eng">MeSH Indexing http://www.nlm.nih.gov/mesh</lom:string>
</lom:source>
<lom:taxon>
<lom:id>D016896/Q000000/N</lom:id>
<lom:entry>
<lom:string language="fre">résultat thérapeutique//N</lom:string>
<lom:string language="eng">treatment outcome//N</lom:string>
</lom:entry>
</lom:taxon>
</lom:taxonPath>
<lom:taxonPath>
<lom:source>
<lom:string language="fre">MeSH http://mesh.inserm.fr/mesh/</lom:string>
<lom:string language="eng">MeSH Indexing http://www.nlm.nih.gov/mesh</lom:string>
</lom:source>
<lom:taxon>
<lom:id>D004359/Q000000/N</lom:id>
<lom:entry>
<lom:string language="fre">association de médicaments//N</lom:string>
<lom:string language="eng">drug therapy, combination//N</lom:string>
</lom:entry>
</lom:taxon>
</lom:taxonPath>
<lom:taxonPath>
<lom:source>
<lom:string language="fre">MeSH http://mesh.inserm.fr/mesh/</lom:string>
<lom:string language="eng">MeSH Indexing http://www.nlm.nih.gov/mesh</lom:string>
</lom:source>
<lom:taxon>
<lom:id>D000068299/Q000627/O</lom:id>
<lom:entry>
<lom:string language="fre">Xinafoate de salmétérol/usage thérapeutique/O</lom:string>
<lom:string language="eng">Salmeterol Xinafoate/therapeutic use/Y</lom:string>
</lom:entry>
</lom:taxon>
</lom:taxonPath>
<lom:taxonPath>
<lom:source>
<lom:string language="fre">MeSH http://mesh.inserm.fr/mesh/</lom:string>
<lom:string language="eng">MeSH Indexing http://www.nlm.nih.gov/mesh</lom:string>
</lom:source>
<lom:taxon>
<lom:id>D000069447/Q000627/O</lom:id>
<lom:entry>
<lom:string language="fre">Bromure de tiotropium/usage thérapeutique/O</lom:string>
<lom:string language="eng">Tiotropium Bromide/therapeutic use/Y</lom:string>
</lom:entry>
</lom:taxon>
</lom:taxonPath>
</lom:classification>
</lom:lom>